University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital
Search Site | Find a Doctor

Chi-Yuan Hsu, M.D.

Kidney specialist

Clinics

Nephrology, Hypertension and Metabolism Practice at Parnassus
400 Parnassus Ave., Fifth Floor
San Francisco, CA 94143-0532
Phone: (415) 353-2507
Fax: (415) 353-2568
New Referrals: (415) 476-2173
New Referrals Fax: (415) 476-3381

Hours: Monday to Friday
8 a.m. – 5 p.m.

More about Chi-Yuan Hsu

Additional Languages

Cantonese
Mandarin

Education

Harvard University School of Medicine 1993

Residencies

Boston's Beth Israel Hospital, Internal Medicine 1996

Fellowships

Massachusetts General Hospital, Nephrology 1998

Selected Research and Publications

  1. Park M, Vittinghoff E, Liu KD, Shlipak MG, Hsu CY. Urine Biomarkers Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule-1 (KIM-1) Have Different Patterns in Heart Failure Exacerbation. Biomark Insights. 2013; 8:15-8.
  2. Tuot DS, Plantinga LC, Judd SE, Muntner P, Hsu CY, Warnock DG, Gutiérrez OM, Safford M, Powe NR, McClellan WM. Healthy behaviors, risk factor control and awareness of chronic kidney disease. Am J Nephrol. 2013; 37(2):135-43.
  3. Liu KD, Yang W, Anderson AH, Feldman HI, Demirjian S, Hamano T, He J, Lash J, Lustigova E, Rosas SE, Simonson MS, Tao K, Hsu CY. Urine neutrophil gelatinase-associated lipocalin levels do not improve risk prediction of progressive chronic kidney disease. Kidney Int. 2013 May; 83(5):909-14.
  4. Bansal N, Fan D, Hsu CY, Ordonez JD, Marcus GM, Go AS. Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease. Circulation. 2013 Feb 5; 127(5):569-74.
  5. Hsu RK, McCulloch CE, Dudley RA, Lo LJ, Hsu CY. Temporal Changes in Incidence of Dialysis-Requiring AKI. J Am Soc Nephrol. 2013 Jan; 24(1):37-42.
  6. Bansal N, Whooley MA, Regan M, McCulloch CE, Ix JH, Epel E, Blackburn E, Lin J, Hsu CY. Association between Kidney Function and Telomere Length: The Heart and Soul Study. Am J Nephrol. 2012; 36(5):405-11.
  7. Hsu RK, Hsu CY. We Can Diagnose AKI "Early". Clin J Am Soc Nephrol. 2012 Nov; 7(11):1741-2.
  8. Park M, Hsu CY, Li Y, Mishra RK, Keane M, Rosas SE, Dries D, Xie D, Chen J, He J, Anderson A, Go AS, Shlipak MG. Associations between kidney function and subclinical cardiac abnormalities in CKD. J Am Soc Nephrol. 2012 Oct; 23(10):1725-34.
  9. Huang HL, Hsu CC, Peng WD, Yen YY, Chen T, Hu CY, Shi HY, Lee CH, Chen FL, Lin PL. Analysis of influential factors associated with the smoking behavior of aboriginal schoolchildren in remote Taiwanese mountainous areas. J Sch Health. 2012 Jul; 82(7):318-27.
  10. Shau WY, Shao YY, Yeh YC, Lin ZZ, Kuo R, Hsu CH, Hsu C, Cheng AL, Lai MS. Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma. Oncologist. 2012; 17(6):856-62.
  11. Park M, Shlipak MG, Katz R, Agarwal S, Ix JH, Hsu CY, Peralta CA. Subclinical cardiac abnormalities and kidney function decline: the multi-ethnic study of atherosclerosis. Clin J Am Soc Nephrol. 2012 Jul; 7(7):1137-44.
  12. Bansal N, Vittinghoff E, Plantinga L, Hsu CY. Does chronic kidney disease modify the association between body mass index and cardiovascular disease risk factors. J Nephrol. 2012 May-Jun; 25(3):317-24.
  13. Tuot DS, Plantinga LC, Hsu CY, Powe NR. Is awareness of chronic kidney disease associated with evidence-based guideline-concordant outcomes? Am J Nephrol. 2012; 35(2):191-7.
  14. Hsu CY. Brenner and Rector's The Kidney. Chapter 19: Epidemiology of Kidney Disease. 2012; 1:728-741.
  15. Shao YY, Chen PJ, Lin ZZ, Huang CC, Ding YH, Lee YH, Hsu CH, Cheng AL. Impact of baseline hepatitis B viral DNA levels on survival of patients with advanced hepatocellular carcinoma. Anticancer Res. 2011 Nov; 31(11):4007-11.
  16. Yang SH, Kuo YH, Tien YW, Hsu C, Hsu CH, Kuo SH, Cheng AL. Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not participate in clinical trials. Oncology. 2011; 81(3-4):143-50.
  17. Hsu CY, Propert K, Xie D, Hamm L, He J, Miller E, Ojo A, Shlipak M, Teal V, Townsend R, Weir M, Wilson J, Feldman H. Measured GFR does not outperform estimated GFR in predicting CKD-related complications. J Am Soc Nephrol. 2011 Oct; 22(10):1931-7.
  18. Bansal N, Hsu CY, Chandra M, Iribarren C, Fortmann SP, Hlatky MA, Go AS. Potential role of differential medication use in explaining excess risk of cardiovascular events and death associated with chronic kidney disease: a cohort study. BMC Nephrol. 2011; 12:44.
  19. Chang WC, Wahlqvist ML, Chang HY, Hsu CC, Lee MS, Wang WS, Hsiung CA. A bean-free diet increases the risk of all-cause mortality among Taiwanese women: the role of the metabolic syndrome. Public Health Nutr. 2012 Apr; 15(4):663-72.
  20. Tuot DS, Plantinga LC, Hsu CY, Jordan R, Burrows NR, Hedgeman E, Yee J, Saran R, Powe NR. Chronic kidney disease awareness among individuals with clinical markers of kidney dysfunction. Clin J Am Soc Nephrol. 2011 Aug; 6(8):1838-44.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions by logging on to UCSF Profiles.